Difficulty: Medium
Average Score: 92%
Practice
Indicate the beta adrenoreceptor antagonist, which has partial beta-agonist activity:
Correct answer
C
Rationale
In this question, the correct answer is C) Pindolol. Pindolol is a beta-adrenergic antagonist that possesses partial beta-agonist activity. This means that it can exhibit both antagonist and agonist effects on beta-adrenergic receptors.
Propranolol (option A) is a non-selective beta-blocker without intrinsic sympathomimetic activity. Metoprolol (option B) is a selective beta-1 blocker with no intrinsic sympathomimetic activity. Betaxolol (option D) is a selective beta-1 blocker without intrinsic sympathomimetic activity.
Educationally, understanding the concept of partial beta-agonist activity in pharmacology is crucial for nurses and healthcare professionals. It impacts the way these medications interact with the body's adrenergic receptors and how they can have varying effects based on their activity. Pindolol's unique profile makes it a valuable option in certain clinical scenarios where a balance of beta-adrenergic effects is desired. Understanding these nuances helps in making informed decisions when selecting the most appropriate pharmacological interventions for patients.
Propranolol (option A) is a non-selective beta-blocker without intrinsic sympathomimetic activity. Metoprolol (option B) is a selective beta-1 blocker with no intrinsic sympathomimetic activity. Betaxolol (option D) is a selective beta-1 blocker without intrinsic sympathomimetic activity.
Educationally, understanding the concept of partial beta-agonist activity in pharmacology is crucial for nurses and healthcare professionals. It impacts the way these medications interact with the body's adrenergic receptors and how they can have varying effects based on their activity. Pindolol's unique profile makes it a valuable option in certain clinical scenarios where a balance of beta-adrenergic effects is desired. Understanding these nuances helps in making informed decisions when selecting the most appropriate pharmacological interventions for patients.